Literature DB >> 11730994

Alternating chemoradiotherapy for nasopharyngeal cancer using cisplatin and 5-fluorouracil: a preliminary report of phase II study.

N Fuwa1, M Kano, T Toita, N Shikama, T Kodaira, A Matsumoto, M Kamata, K Furutani, H Tatibana.   

Abstract

Alternating chemoradiotherapy was performed in 35 patients with locally advanced nasopharyngeal cancer. The median duration of follow-up was 20 months, and the 2-year progression free and overall survival rates were 83% (95% confidence interval: 66~101%) and 94% (95% CI: 84~105%), respectively. This method may be useful in treating nasopharyngeal cancer.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11730994     DOI： 10.1016/s0167-8140(01)00422-4

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN： 0167-8140            Impact factor:   6.280


  2 in total

1.  Alternating chemoradiotherapy in patients with nasopharyngeal cancer: prognostic factors and proposal for individualization of therapy.

Authors:  Yoko Goto; Takeshi Kodaira; Nobukazu Fuwa; Nobutaka Mizoguchi; Rie Nakahara; Motoo Nomura; Natsuo Tomita; Hiroyuki Tachibana
Journal:  J Radiat Res       Date:  2012-08-24       Impact factor: 2.724

2.  Preliminary treatment results of proton beam therapy with chemoradiotherapy for stage I-III esophageal cancer.

Authors:  Akinori Takada; Tatsuya Nakamura; Kanako Takayama; Chiyoko Makita; Motohisa Suzuki; Yusuke Azami; Takahiro Kato; Iwao Tsukiyama; Masato Hareyama; Yasuhiro Kikuchi; Takashi Daimon; Yutaka Toyomasu; Noriko Ii; Yoshihito Nomoto; Hajime Sakuma; Nobukazu Fuwa
Journal:  Cancer Med       Date:  2016-01-24       Impact factor: 4.452
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.